Antiretroviral Generics in Africa: How Local Production Is Transforming HIV Treatment Access
African-made antiretroviral generics are transforming HIV treatment access, with the first WHO-prequalified TLD produced in Kenya and delivered to Mozambique in 2025. Local manufacturing is cutting costs, improving supply chains, and building health sovereignty across the continent.
Read More